<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">

  <url>
    <loc>https://www.basisreport.com/news/enph-enphase-ceo-buys-above-analyst-target</loc>
    <lastmod>2026-06-04T17:08:11.444Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>Basis Report News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-04T17:08:11.444Z</news:publication_date>
      <news:title>Enphase CEO Buys $337K in Stock Above Analyst Target</news:title>
    </news:news>
  </url>

  <url>
    <loc>https://www.basisreport.com/news/s-sentinelone-earnings-miss-restructuring</loc>
    <lastmod>2026-06-04T13:05:42.753Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>Basis Report News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-04T13:05:42.753Z</news:publication_date>
      <news:title>SentinelOne Posts Earnings Miss and Restructuring Charge</news:title>
    </news:news>
  </url>

  <url>
    <loc>https://www.basisreport.com/news/czr-caesars-fertitta-buyout-fairness-probe</loc>
    <lastmod>2026-06-04T08:06:41.032Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>Basis Report News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-04T08:06:41.032Z</news:publication_date>
      <news:title>Caesars Agrees to Fertitta Buyout Amid Fairness Probe</news:title>
    </news:news>
  </url>

  <url>
    <loc>https://www.basisreport.com/news/mgm-confirms-48-takeover-bid-barry-diller</loc>
    <lastmod>2026-06-03T17:04:59.167Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>Basis Report News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-03T17:04:59.167Z</news:publication_date>
      <news:title>MGM Confirms $48.30 Takeover Bid From Barry Diller</news:title>
    </news:news>
  </url>

  <url>
    <loc>https://www.basisreport.com/news/hbm-hudbay-minerals-buyback-barclays-overweight</loc>
    <lastmod>2026-06-03T13:06:09.851Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>Basis Report News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-03T13:06:09.851Z</news:publication_date>
      <news:title>TSX Approves Hudbay 5% Buyback; Barclays Goes Overweight</news:title>
    </news:news>
  </url>

  <url>
    <loc>https://www.basisreport.com/news/rum-rumble-securities-investigation-share-supply</loc>
    <lastmod>2026-06-03T12:01:58.496Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>Basis Report News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-03T12:01:58.496Z</news:publication_date>
      <news:title>Securities Investigation Hits Rumble Inc. at the Worst Possible Time</news:title>
    </news:news>
  </url>

  <url>
    <loc>https://www.basisreport.com/news/ntnx-nutanix-q3-earnings-beat-cco-insider-sales</loc>
    <lastmod>2026-06-03T08:05:42.422Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>Basis Report News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-03T08:05:42.422Z</news:publication_date>
      <news:title>Nutanix Q3 Earnings Beat, CCO Sells $2.7M in Shares</news:title>
    </news:news>
  </url>

  <url>
    <loc>https://www.basisreport.com/news/orka-oruka-il23-rights-expansion-ibd-delay</loc>
    <lastmod>2026-06-02T19:00:36.077Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>Basis Report News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-02T19:00:36.077Z</news:publication_date>
      <news:title>Oruka Therapeutics Expands IL-23 Drug Rights But Delays Key IBD Trial</news:title>
    </news:news>
  </url>
</urlset>